Clinical Trial Update: A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing IV BCV versus IV CDV for treating adenovirus infections after allogeneic hematopoietic cell transplantation is in recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infections

Drugs mentioned

• BCV
• CDV

Snippet

Sponsor: SymBio Pharmaceuticals | Conditions: Adenovirus Infections | Phase 3 | Status: RECRUITING